Korsana Biosciences, Inc. (KRSA)
31.65
+0.37
(+1.18%)
USD |
NASDAQ |
Nov 13, 16:00
31.58
-0.07
(-0.22%)
After-Hours: 19:59
Korsana Biosciences Price to Book Value : 3.681 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 3.681 |
| November 12, 2026 | 3.638 |
| November 11, 2026 | 3.703 |
| November 10, 2026 | 3.618 |
| November 09, 2026 | 3.625 |
| November 06, 2026 | 3.611 |
| November 05, 2026 | 3.539 |
| November 04, 2026 | 3.554 |
| November 03, 2026 | 3.717 |
| November 02, 2026 | 3.682 |
| October 30, 2026 | 3.506 |
| October 29, 2026 | 3.515 |
| October 28, 2026 | 3.502 |
| October 27, 2026 | 3.497 |
| October 26, 2026 | 3.732 |
| October 23, 2026 | 3.642 |
| October 22, 2026 | 3.888 |
| October 21, 2026 | 3.785 |
| October 20, 2026 | 3.609 |
| October 19, 2026 | 3.653 |
| October 16, 2026 | 3.766 |
| October 15, 2026 | 3.914 |
| October 14, 2026 | 3.992 |
| October 13, 2026 | 3.682 |
| October 12, 2026 | 3.959 |
| Date | Value |
|---|---|
| October 09, 2026 | 3.945 |
| October 08, 2026 | 3.897 |
| October 07, 2026 | 3.681 |
| October 06, 2026 | 3.695 |
| October 05, 2026 | 3.573 |
| October 02, 2026 | 3.546 |
| October 01, 2026 | 3.629 |
| September 30, 2026 | 3.722 |
| September 29, 2026 | 4.064 |
| September 28, 2026 | 3.685 |
| September 25, 2026 | 3.705 |
| September 24, 2026 | 4.445 |
| September 23, 2026 | 3.860 |
| September 22, 2026 | 4.181 |
| September 21, 2026 | 3.969 |
| September 18, 2026 | 4.182 |
| September 17, 2026 | 4.030 |
| September 16, 2026 | 3.733 |
| September 15, 2026 | 3.834 |
| September 14, 2026 | 3.778 |
| September 11, 2026 | 3.813 |
| September 10, 2026 | 2.935 |
| September 09, 2026 | 3.131 |
| September 08, 2026 | 2.811 |
| September 04, 2026 | 3.556 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Q32 Bio, Inc. | 0.9051 |
| IRulya Therapeutics, Inc. | -- |
| Climb Bio, Inc. | 2.622 |
| PepGen Inc. | 2.93 |
| Bridgebio Oncology Therapeutics, Inc. | 0.5852 |
Price to Book Value Related Metrics
| PS Ratio | 117.95 |
| Price | 31.65 |
| Earnings Yield | -41.31% |
| Market Cap | 1.441B |